Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001193125-25-282917·Hawryluk P. Kent
Schedule 13G ownership disclosure
MBX Biosciences Inc
Common Stock, par value $0.0001 per share · CUSIP: 55287L101
Event date: 2025-09-30
- Filing-level shares
- 1,995,759
- Percent of class
- 4.3%
- P. Kent Hawryluk
Shares: 1,995,759 · Class: 4.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-25-282917
- Form type
- SCHEDULE 13G/A
- Filer
- Hawryluk P. Kent
- CIK
- CIK 1673991
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership